Containment Level 3 (CL3) for Tuberculosis research at the Research Institute of the McGill University Health Centre
The RI MUHC has a 535 m2 CL3 (also known as containment Level 3) Facility for TB research that meets highest safety standards defined by Canadian guidelines (PHAC and CFIA). Work carried out in this Facility includes all experimental procedures where there is manipulation of live Mycobacterium tuberculosis. The Facility is available to RI MUHC researcher, affiliated researchers/collaborators and external researchers working on tuberculosis. All work to be carried out in the CL3 Lab must follow the established SOPs, as defined in the Facility's SOP manual.
The RI MUHC CL3 Facility comprises one room for bacterial manipulation and an adjoining room for experiments. Because work done in the RI MUHC CL3 lab must follow strict adherence to procedure, once a set of investigations is approved, the facility manager will oversee training and provide both guidance to researchers and monitoring of experiments.
For further information on the RI MUHC CL3 Facility, please contact Fiona McIntosh, Facility manager, at: